Literature DB >> 1752466

Faecal bile acid excretion in children with inflammatory bowel disease.

J Ejderhamn1, J J Rafter, B Strandvik.   

Abstract

Faecal bile acid excretion and intestinal transit time were studied in 18 children with inflammatory bowel disease in clinical remission and with normal stools: 16 with ulcerative colitis, two with Crohn's colitis, mean age 14 years (range 10-17 years). Five healthy children, mean age 12.4 years (range 10-17 years), were studied as control subjects. Most patients were taking sulphasalazine, but none were taking steroids. Transit time was determined by carmine and did not differ between groups. Faeces were collected for 72 hours, and faecal water was prepared by centrifugation of faeces at 15,000 x g for two hours. Bile acids in total faeces and faecal water were studied using capillary gas-liquid chromatography-mass spectrometry. Faecal excretion of total bile acids, unconjugated bile acids, and glycine and taurine conjugates were significantly increased in patients as was faecal water excretion of total bile acids, particularly the taurine conjugates and cholic and chenodeoxycholic acids. Total concentrations of bile acids in faeces and faecal water were two to five times higher in patients. The children with inflammatory bowel disease in clinical remission had high excretion and concentration rates of bile acids, especially taurine conjugates, in both total faeces and faecal water, a finding of considerable interest in the pathogenesis of malignancy in these diseases.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1752466      PMCID: PMC1379165          DOI: 10.1136/gut.32.11.1346

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  34 in total

1.  [Studies on the quantitative evaluation of thin-layer chromatography. 2. Separation and determination of bile acids].

Authors:  H GAENSHIRT; F W KOSS; K MORIANZ
Journal:  Arzneimittelforschung       Date:  1960-11

2.  Cellular toxicity of human faecal water--possible role in aetiology of colon cancer.

Authors:  J Rafter; U Geltner; R Bruce
Journal:  Scand J Gastroenterol Suppl       Date:  1987

3.  Colorectal carcinoma in patients with Crohn's disease.

Authors:  S R Hamilton
Journal:  Gastroenterology       Date:  1985-08       Impact factor: 22.682

4.  Bacteria and the aetiology of cancer of the large bowel.

Authors:  V Aries; J S Crowther; B S Drasar; M J Hill; R E Williams
Journal:  Gut       Date:  1969-05       Impact factor: 23.059

5.  Proliferative activity of rectal mucosa and soluble fecal bile acids in patients with normal colons and in patients with colonic polyps or cancer.

Authors:  J Stadler; K S Yeung; R Furrer; N Marcon; H S Himal; W R Bruce
Journal:  Cancer Lett       Date:  1988-01       Impact factor: 8.679

6.  Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centres.

Authors:  S N Gyde; P Prior; R N Allan; A Stevens; D P Jewell; S C Truelove; R Lofberg; O Brostrom; G Hellers
Journal:  Gut       Date:  1988-02       Impact factor: 23.059

7.  Cellular toxicity of fecal water depends on diet.

Authors:  J J Rafter; P Child; A M Anderson; R Alder; V Eng; W R Bruce
Journal:  Am J Clin Nutr       Date:  1987-03       Impact factor: 7.045

8.  Relative risk of colorectal cancer after cholecystectomy. A multicentre case-control study.

Authors:  A Mamianetti; R O Cinto; D Altolaguirre; O A Bosicio; A Heidenreich; M Salomón
Journal:  Int J Colorectal Dis       Date:  1988-11       Impact factor: 2.571

9.  Effects of 4-week treatment with gastric carcinogens and enhancing agents on proliferation of gastric mucosa cells in rats.

Authors:  H Ohgaki; Z Szentirmay; M Take; T Sugimura
Journal:  Cancer Lett       Date:  1989-07-15       Impact factor: 8.679

10.  Large bowel cancer risk in cholelithiasis and after cholecystectomy. Postmortem study.

Authors:  N F Breuer; B Katschinski; E Mörtl; L D Leder; H Goebell
Journal:  Digestion       Date:  1988       Impact factor: 3.216

View more
  5 in total

Review 1.  Role of commensal gut bacteria in inflammatory bowel diseases.

Authors:  Gunnar Loh; Michael Blaut
Journal:  Gut Microbes       Date:  2012-10-11

2.  Effect of bile salts on colonic mucus secretion in isolated vascularly perfused rat colon.

Authors:  A Barcelo; J Claustre; F Toumi; G Burlet; J A Chayvialle; J C Cuber; P Plaisancié
Journal:  Dig Dis Sci       Date:  2001-06       Impact factor: 3.199

3.  Rapid cholesterol nucleation time and cholesterol gall stone formation after subtotal or total colectomy in humans.

Authors:  I Makino; K Chijiiwa; H Higashijima; S Nakahara; M Kishinaka; S Kuroki; R Mibu
Journal:  Gut       Date:  1994-12       Impact factor: 23.059

4.  Very long O-antigen chains enhance fitness during Salmonella-induced colitis by increasing bile resistance.

Authors:  Robert W Crawford; A Marijke Keestra; Sebastian E Winter; Mariana N Xavier; Renée M Tsolis; Vladimir Tolstikov; Andreas J Bäumler
Journal:  PLoS Pathog       Date:  2012-09-20       Impact factor: 6.823

5.  Farnesoid X receptor (FXR) activation and FXR genetic variation in inflammatory bowel disease.

Authors:  Rian M Nijmeijer; Raffaella M Gadaleta; Saskia W C van Mil; Adriaan A van Bodegraven; J Bart A Crusius; Gerard Dijkstra; Daan W Hommes; Dirk J de Jong; Pieter C F Stokkers; Hein W Verspaget; Rinse K Weersma; C Janneke van der Woude; Janneke M Stapelbroek; Marguerite E I Schipper; Cisca Wijmenga; Karel J van Erpecum; Bas Oldenburg
Journal:  PLoS One       Date:  2011-08-22       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.